Home
>
National Drug Code (NDC)
>
Tacrolimus
Tacrolimus - 0378-2046-05 - (Tacrolimus)
Drug Information of Tacrolimus
| Product NDC: | 0378-2046 |
| Proprietary Name: | Tacrolimus |
| Non Proprietary Name: | Tacrolimus |
| Active Ingredient(s): | 1 mg/1 & nbsp; Tacrolimus |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Tacrolimus
| Product NDC: | 0378-2046 |
| Labeler Name: | Mylan Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA090596 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120723 |
Package Information of Tacrolimus
| Package NDC: | 0378-2046-05 |
| Package Description: | 500 CAPSULE in 1 BOTTLE, PLASTIC (0378-2046-05) |
NDC Information of Tacrolimus
| NDC Code | 0378-2046-05 |
| Proprietary Name | Tacrolimus |
| Package Description | 500 CAPSULE in 1 BOTTLE, PLASTIC (0378-2046-05) |
| Product NDC | 0378-2046 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Tacrolimus |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20120723 |
| Marketing Category Name | ANDA |
| Labeler Name | Mylan Pharmaceuticals Inc. |
| Substance Name | TACROLIMUS |
| Strength Number | 1 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Calcineurin Inhibitor Immunosuppressant [EPC],Calcineurin Inhibitors [MoA] |
